CJC-1295 (no DAC) + Ipamorelin + GHRP-2 blend_Dosage, benefits & legal status
Also known as CJC-1295 + Ipamorelin + GHRP-2, Mod GRF 1-29 + Ipamorelin + GHRP-2, CJC/Ipa/GHRP-2, triple GH blend
The two-peptide CJC and ipamorelin blend with a third secretagogue folded in, at a ratio you cannot adjust.
Common vial size is what vendors typically sell, not a recommendation. Enter your own vial in the calculator.
What is CJC-1295 (no DAC) + Ipamorelin + GHRP-2 blend?
Plain language first. The technical label stays, but it never stands alone.Overview
It puts three peptides that each push the pituitary to release growth hormone into a single injection. Two of them, ipamorelin and GHRP-2, act on the same receptor, so the third peptide mostly adds hunger and prolactin risk rather than a new pathway.
What it's used for
Raising growth hormone release for body composition, recovery, and sleep, with one injection instead of three.
How does CJC-1295 (no DAC) + Ipamorelin + GHRP-2 blend work?
What it does in the body, and where.CJC-1295 (no DAC) + ipamorelin + GHRP-2 combines three growth hormone secretagogues. None has a controlled human trial as sold, and the blend has never been tested.
- 01CJC-1295 (no DAC) acts like the body's own GHRHIt binds the GHRH receptor on the pituitary, the same signal the hypothalamus uses to call for growth hormone.
- 02Ipamorelin and GHRP-2 act on the same receptorBoth bind the ghrelin receptor. Ipamorelin is the cleaner of the two; GHRP-2 adds hunger and can raise prolactin and cortisol. Stacking two drugs on one receptor adds side effects more than it adds signal.
- 03The combination is an assumption, not a findingNobody has tested this vial against the two-peptide blend or any component alone.
A schematic of the compound's mechanism, not a diagnostic image.
What else is it used for?
Each use below carries its own evidence level. Approved means regulators have cleared it for that purpose. Investigational means it is in trials. Early research means it is being studied and is not established.
- Raising growth hormone release through two receptors at onceResearch only
- Convenience, since it puts three peptides into one injectionResearch only
At a glance
Four things to know about CJC-1295 (no DAC) + Ipamorelin + GHRP-2 blend
Evidence
Category
Growth hormone
Common vial
Varies
Half-life
No usable human figure for any of the three
How much, and do you cycle it?
The range, and whether you take breaks.0.1 mg CJC-1295 (no DAC) per dose (the rest follows your ratio), daily, often at night. Cycled on the same schedule quoted for the two-peptide version, usually 8 to 12 weeks on and 4 off Community practice
Sustained exposure to a ghrelin-receptor peptide blunts the growth hormone response to a later dose, which is the documented reason for cycling this family. No study has tested this blend on any schedule, and in a single vial the schedule applies to all three at once.
Source: 24-hour GHRP infusion attenuates the response to a later GHRP bolus (J Clin Endocrinol Metab, 1993)
No usable human figure for any of the threeNo figure
Ipamorelin is put at about 2 hours, a figure that traces to no primary source. CJC-1295 without DAC has never been measured in a person. A blend of three cannot have a single number when none of the three has a solid one.
You can compare this against the whole library to see where it sits.
How do I dose and price it?
Enter your vial and your dose. Pick a mix. We show the draw and the cost.The vial holds a fixed amount of drug. Adding more water does not make more drug, it just spreads it thinner, so you draw a bigger number on the syringe for the same dose.
The only ratio printed on the vendor pages checked was 2 mg of each. A separate version made with CJC-1295 with DAC also exists; the DAC form behaves so differently that the two products are not interchangeable, so check which CJC-1295 your label names.
Pick your vial to see concentrations and a draw.
Choose your mix
Measuring the water1 mL = one full 100-unit syringe.
Your draw
What one draw delivers
The same arithmetic as the calculator, worked out for the vials vendors sell.Dose anchored to CJC-1295 (no DAC), at the commonly cited 0.1 mg per dose. Each table assumes one draw per dose. If you split it across more injections, divide the reading by the number of injections.
| CJC-1295 (no DAC) dose | 1 mL water | 2 mL water | 3 mL water |
|---|---|---|---|
| 0.1 mg | 5.0 units
| 10.0 units
| 15.0 units
|
No published human study establishes a dose for this blend. The anchor comes from vendor and community practice and is set on one component, because a blend is one draw.
CJC-1295 (no DAC) is usually cited at about 100 mcg, ipamorelin at 200 to 300 mcg, and GHRP-2 at 100 to 300 mcg. One draw from a 1:1:1 vial at the CJC-1295 dose delivers 100 mcg of each, below the usual ipamorelin range and at the bottom of the GHRP-2 range. The fixed ratio means you cannot raise one without raising all three.
CJC-1295 (no DAC) + Ipamorelin + GHRP-2 blend starts at $95.00 across 1 vendor.
3 listings, last read Oct 24, 2026. Shipping and card fees are not included.
How do you store it?
Before mixing, and after.Dry powder in the freezer or fridge. Once mixed, fridge, and use within about a month.
Unmixed lyophilized CJC-1295 (no DAC) + Ipamorelin + GHRP-2 blend keeps for a long time cold. Once you add water the clock starts: most reconstituted vials hold up for roughly 28 to 30 days at fridge temperature. Keep it out of light, and do not freeze it after mixing.
What are the side effects and cautions?
Known cautions and warnings for this compound.Check which CJC-1295 is in your vial. A with-DAC version of this blend exists and behaves so differently that it changes the whole schedule. If your label does not give the amount of each peptide, the dose cannot be worked out.
Who should avoid it
- Active cancer, as a precaution with anything raising growth hormone
- Pregnancy
- Banned in drug-tested sport
Stop and get help
- Signs of an allergic reaction
- Persistent milky nipple discharge, a sign of raised prolactin from the GHRP-2
Common effects
- Injection-site reactions
- Increased hunger, from the GHRP-2
- Water retention
- Tiredness after dosing
- Tingling in the hands
- This is a blend, so the cautions of all three peptides apply at once. It is also harder to tell which one caused a reaction.
Where this page says nothing is established, that means nobody has studied it, not that a compound is safe.
Is CJC-1295 (no DAC) + Ipamorelin + GHRP-2 blend approved?
And where the numbers on this page come from.No. CJC-1295 (no DAC) + Ipamorelin + GHRP-2 blend is not approved for any use, anywhere. It is sold labeled for laboratory research only, and there is no legal route to buy it for human use.
- Approval statusResearch only
- RouteUnder the skin (subcutaneous)
- Checked31 October 2026
- DoseFrom community reports. No regulator or trial established this dose.
- Vial sizeFrom what vendors typically list; not a recommendation.
- SourcesNone traced yet.
What has happened recently
We have not yet written a full regulatory note for this compound. The status above is current as of the date shown.
Banned in drug-tested sport. Most research peptides are prohibited under WADA's S0 category, which covers any substance with no approval from any regulatory authority for human use. That means a compound can be banned without ever being named on the prohibited list. Check with your own anti-doping authority rather than assuming absence from the list means permitted.
You can compare this against the whole library, or read how to check a seller.
What else is like CJC-1295 (no DAC) + Ipamorelin + GHRP-2 blend?
Others in Growth hormone peptides, side by side.If you're weighing CJC-1295 (no DAC) + Ipamorelin + GHRP-2 blend, it's worth reading Ghrelin (lenomorelin), GHRP-1, and GHRP-3 in the same class.
The two-peptide CJC and ipamorelin blend with a third secretagogue folded in, at a ratio you cannot adjust.
- Dose
- 0.1 mg CJC-1295 (no DAC) per dose (the rest follows your ratio)
- How often
- Daily, often at night
The hormone behind every ghrelin-receptor card on this site, made in the stomach and switched on by an eight-carbon fatty chain. Infused in small trials after stomach surgery and in wasting conditions, it was never approved.
- Dose
- 2 to 3 mcg/kg per infusion (phase 2 trials)
- How often
- Twice daily for 10 days to 3 weeks (most trials); once daily for 8 weeks in one
The seven-amino-acid member of the family, studied early and then left behind.
- Dose
- Research only
- How often
- Not established
Named on the WADA banned list, and almost undocumented anywhere else.
- Dose
- Research only
- How often
- Not established
Guides for this compound
- How to Reconstitute a Peptide
Mix peptide powder with bacteriostatic water, step by step.
- How to Read an Insulin Syringe
Read the units, convert to millilitres, and draw the exact dose.
- mcg vs mg: The Peptide Dosing Mistake to Avoid
Your vial says mg and your protocol says mcg. Here is the conversion and how to check it.
- Why Does My Peptide Injection Itch or Welt
Injection-site irritation, a histamine reaction, or a true allergy, and how to tell them apart.
- How to Read a Peptide COA
What the purity number does and does not tell you, and how to spot an edited report.
Sources
No primary source has been traced for this compound yet. Treat everything on this page as unverified until one is. How we grade evidence